Skip to main content

Advertisement

SpringerLink
Log in

LDH (Lactate Dehydrogenase): A Biochemical Marker for the Prediction of Adverse Outcomes in Pre-eclampsia and Eclampsia

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Objective

The aim of the study was to find out the role of Serum lactate dehydrogenase in prediction of adverse outcomes of PE & E i.e., severity of disease and occurrence of complications.

Materials and Methods

This study was conducted in the Department of Obstetrics and Gynaecology, MGM Medical College, Indore. A total of 200 women were studied; they were divided into control (n = 100), severe pre-eclampsia (n = 32), eclampsia (n = 68). Demographic and hematological parameters were studied including LDH levels.

Results

The incidence of severe pre-eclampsia—1.2 % & Eclampsia 2.7 %, PE & E patients were significantly younger, with low gravidity and parity. They had significantly increased systolic and diastolic pressure, liver enzymes, uric acid, urine albumin, and LDH levels. Serum urea and creatinine were normal in majority of cases. The symptoms and complications of PE along with perinatal mortality were increased significantly in patients with LDH >800 IU/l compared with those who had lower levels. Complications like Retinopathy, ARF, Abruptio, DIC, CVA, MODS, Shock were also associated with high level of serum LDH >800 IU/L. Low birth weight of babies was also associated with high level of serum LDH levels in PE & E patients. The incidence of poor perinatal outcome was higher in PE & E patients with high serum LDH level (>600 IU/L).

Conclusion

LDH is the earliest marker seen in blood during hypoxia and oxidative stress. It is a useful biochemical marker that reflects the severity of and the occurrence of complications of PE & E; these are preventable if identified at an earlier stage and adequately managed at a higher center. Test is easily available, so screening of all cases of PE & E with LDH levels must be made mandatory.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Craici I, Wagner S, Garovic VD. Pre-eclampsia and future cardiovascular risk: formal risk factor or failed stress test? Ther Adv Cardiovasc Dis. 2008;2(4):249–59.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Cunningham FC, Leveno KJ, Bloom SL, et al. Williams obstetrics. 23rd ed. New York: McGraw-Hill; 2010. p. 706.

    Google Scholar 

  3. Tsoi SCM, Zheng J, Xu F, et al. Differential expression of lactate dehydrogenase isozymes (LDH) in human placenta with high expression of LDH-A4 isozyme in the endothelial cells of pre-eclampsia villi. Placenta. 2001;22(317):22.

    Google Scholar 

  4. Kay HH, Zhu S, Tsoi S. Hypoxia and lactate production in trophoblast cells. Placenta. 2007;28(8-9):854–60.

    Article  CAS  PubMed  Google Scholar 

  5. Burd LI, Simmons MA, Makowski EL, et al. Placental production and foetal utilization of lactate and pyruvate. Nature. 1975;254:710–1.

    Article  CAS  PubMed  Google Scholar 

  6. Bougneres PF, Rocchiccioli F, Nurjhan N, et al. Stable isotope determination of plasma lactate conversion into glucose in fasting infants. Am J Physiol. 1995;268:E652–800.

    CAS  PubMed  Google Scholar 

  7. Markert CL, Shaklee JB, Whitt GS. Evolution of a gene: multiple genes for LDH isozymes provide a model of the evolution of gene structure, function and regulation. Science. 1975;189:102–500.

    Article  CAS  PubMed  Google Scholar 

  8. Semenza GL, Roth PH, Fang HM, et al. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 1994;269:23757–63.

    CAS  PubMed  Google Scholar 

  9. Hofmeyr GJ, Belfort M. Proteinuria as a predictor of complications of pre-eclampsia. BMC Med. 2009;7:11.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Tompkins MJ, Thiagarajah S. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids. Am J Obstet Gynecol. 1999;181:304–9.

    Article  CAS  PubMed  Google Scholar 

  11. O’Brien JM, Milligan DA, Barton JR. Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol. 2000;183(4):921–4.

    Article  PubMed  Google Scholar 

  12. O’Brien JM, Shumate SA, Satchwell SL, et al. Maternal benefit to corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome: impact on the rate of regional anesthesia. Am J Obstet Gynecol. 2002;186:475–9.

    Article  PubMed  Google Scholar 

  13. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynaecol. 2004;103(5):1–981.

    Article  Google Scholar 

  14. Ali BS, Ghafoorian J, Alizadeh Sm. Severe pre-eclampsia and eclampsia in Kerman, Iran, complications and outcomes. Med Sci Monit. 2004;10(4):CR163–7.

  15. Demir SC, Evruke C, Ozgunen FT, et al. Factors that influences morbidity and mortality in severe pre-eclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Saudi Med J. 2006;27(7):1015–8.

    PubMed  Google Scholar 

  16. Qublan HS, Ammarin V, Bataineh O. Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe pre-eclampsia. Med Sci Monit. 2005;11(8):CR393–7.

    CAS  PubMed  Google Scholar 

  17. Liu D, Liu H, Zeng W. Clinical analysis of PIH with abnormal liver function in 66 patients. Hunan Yi Ke Da Xue Xue Bao. 1998;23(3):302–24.

    CAS  PubMed  Google Scholar 

  18. Jaiswar SP, Gupta A, Sachan R, et al. Lactic dehydrogenase: a biochemical marker for preeclampsia–eclampsia. J Obstet Gynaecol India. 2011;61(6):645–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Kozic JR, Benton SJ, Hutcheon JA, et al. Abnormal liver function tests as predictors of adverse maternal outcomes in women with pre-eclampsia. J Obstet Gynaecol Can. 2011;33(10):995–1004.

    PubMed  Google Scholar 

  20. Sonagra AD, Dattatreya K, Jayaprakash Murty DS. Serum LDH, ALP and uric acid in hypertensive disorders of pregnancy. Int J Pharm Bio Sci. 2012;2(3):201–9.

    CAS  Google Scholar 

Download references

Compliance with ethical requirements and Conflict of interests

Study was done after taking consent from the cases enrolled and also permissions were taken from Institutional Ethical committee and the authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynaecology, M. Y. Hospital & MGM Medical College, 314, Saket Nagar, Indore, 452018, Madhya Pradesh, India

    Anupama Dave (Associate Professor), Laxmi Maru (Professor and Head of Department) & Astha Jain (Resident)

Authors
  1. Anupama Dave
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laxmi Maru
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Astha Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anupama Dave.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dave, A., Maru, L. & Jain, A. LDH (Lactate Dehydrogenase): A Biochemical Marker for the Prediction of Adverse Outcomes in Pre-eclampsia and Eclampsia. J Obstet Gynecol India 66, 23–29 (2016). https://doi.org/10.1007/s13224-014-0645-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-014-0645-x

Keywords

Search

Navigation